Page last updated: 2024-08-25

dw a 2114r and Leukemia P388

dw a 2114r has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akamatsu, K; Kamisango, K; Koizumi, K; Matsumoto, T; Morikawa, K; Tashiro, T1
Akamatsu, K; Endo, K; Kaiho, S; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K; Tsunenari, T1

Other Studies

2 other study(ies) available for dw a 2114r and Leukemia P388

ArticleYear
Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
    Japanese journal of cancer research : Gann, 1992, Volume: 83, Issue:3

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Resistance; Drug Screening Assays, Antitumor; Leukemia P388; Structure-Activity Relationship

1992
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrosarcoma; Fluorouracil; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Ovarian Neoplasms; Sarcoma, Experimental; Vindesine

1992